Jump to content

Expert Opinion on Biological Therapy: Difference between revisions

From Wikipedia, the free encyclopedia
Content deleted Content added
Cydebot (talk | contribs)
m Robot - Speedily moving category Expert Opinion Journals to Category:Expert Opinion journals per CFDS.
I have updated the impact factor with the latest date and figure
Line 26: Line 26:
The scope includes [[gene therapy]] and [[gene]] transfer technologies, therapeutic [[peptide]]s and [[protein]]s, [[vaccine]]s and [[antibody|antibodies]], and cell- and tissue-based therapies. The journal is published monthly by [[Informa]] and the [[editor-in-chief]] is Michael Morse ([[Duke University Hospital]]). The journal is available online and in paper format.
The scope includes [[gene therapy]] and [[gene]] transfer technologies, therapeutic [[peptide]]s and [[protein]]s, [[vaccine]]s and [[antibody|antibodies]], and cell- and tissue-based therapies. The journal is published monthly by [[Informa]] and the [[editor-in-chief]] is Michael Morse ([[Duke University Hospital]]). The journal is available online and in paper format.


''Expert Opinion on Biological Therapy'' was established in 2001 and according to the [[Journal Citation Reports]] it has a 2012 [[impact factor]] of 3.345. The journal is also indexed in [[MEDLINE]].
''Expert Opinion on Biological Therapy'' was established in 2001 and according to the [[Journal Citation Reports]] it has a 2013 [[impact factor]] of 3.653. The journal is also indexed in [[MEDLINE]].


== Article types ==
== Article types ==

Revision as of 16:59, 7 August 2014

Expert Opinion on Biological Therapy
DisciplineTherapeutics
LanguageEnglish
Publication details
History2001-present
Publisher
FrequencyMonthly
3.345 (2012)
Standard abbreviations
ISO 4Expert Opin. Biol. Ther.
Indexing
ISSN1471-2598 (print)
1744-7682 (web)
LCCN2001243388
OCLC no.48476209
Links

Expert Opinion on Biological Therapy is a peer-reviewed medical journal covering research on all aspects of biological therapy.

It is part of the Expert Opinion series.

The scope includes gene therapy and gene transfer technologies, therapeutic peptides and proteins, vaccines and antibodies, and cell- and tissue-based therapies. The journal is published monthly by Informa and the editor-in-chief is Michael Morse (Duke University Hospital). The journal is available online and in paper format.

Expert Opinion on Biological Therapy was established in 2001 and according to the Journal Citation Reports it has a 2013 impact factor of 3.653. The journal is also indexed in MEDLINE.

Article types

The journal publishes

  • Reviews
  • Original research papers
  • Drug evaluations
  • Technology evaluations
  • Meeting highlights
  • Editorials